AxoGen Inc - רווח נקי למניה אחת בשנים עשר החודשים האחרונים AXGN

AxoGen, Inc. (AXGN) is a global benchmark in nerve regeneration, with biomaterials that have become the industry standard. The company attracts top engineers through an ethical culture and stock options. Its dominance in the peripheral nerve niche eliminates the risk of losing market share. The percentage growth of earnings per share YoY over 12 months demonstrates the business dynamics, where the value -1277.80 captures this metric.

This indicator measures the annual dynamics of net income per share over a rolling period, reflecting the efficiency of business capitalization amid changing borrowing costs. The current value of -1277.80, presented through a year-over-year (TTM) EPS comparison, confirms how the monetization of AxoGen, Inc. (AXGN) unique tissue engineering impacts shareholder value and determines the company's overall financial stability.